Lotus Pharmaceutical Co Ltd
TWSE:1795

Watchlist Manager
Lotus Pharmaceutical Co Ltd Logo
Lotus Pharmaceutical Co Ltd
TWSE:1795
Watchlist
Price: 283 TWD 1.07%
Market Cap: 75.5B TWD

Intrinsic Value

The intrinsic value of one Lotus Pharmaceutical Co Ltd stock under the Base Case scenario is hidden TWD. Compared to the current market price of 283 TWD, Lotus Pharmaceutical Co Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

Lotus Pharmaceutical Co Ltd Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Lotus Pharmaceutical Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Lotus Pharmaceutical Co Ltd looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if Lotus Pharmaceutical Co Ltd is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about Lotus Pharmaceutical Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Lotus Pharmaceutical Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Lotus Pharmaceutical Co Ltd.

Explain Valuation
Compare Lotus Pharmaceutical Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Lotus Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Lotus Pharmaceutical Co Ltd

Current Assets 16.1B
Receivables 5.9B
Other Current Assets 10.2B
Non-Current Assets 23.5B
Long-Term Investments 3.9B
PP&E 3.5B
Intangibles 15.3B
Other Non-Current Assets 795m
Current Liabilities 8.9B
Accounts Payable 1.1B
Short-Term Debt 1.5B
Other Current Liabilities 6.3B
Non-Current Liabilities 8.6B
Long-Term Debt 6.6B
Other Non-Current Liabilities 2B
Efficiency

Free Cash Flow Analysis
Lotus Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Lotus Pharmaceutical Co Ltd

Revenue
18.7B TWD
Cost of Revenue
-7.8B TWD
Gross Profit
10.9B TWD
Operating Expenses
-5.4B TWD
Operating Income
5.4B TWD
Other Expenses
-700m TWD
Net Income
4.7B TWD
Fundamental Scores

Profitability Score
Profitability Due Diligence

Lotus Pharmaceutical Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
Healthy Operating Margin
Positive ROE
Exceptional Gross Margin
hidden
Profitability
Score

Lotus Pharmaceutical Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Lotus Pharmaceutical Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
hidden
Solvency
Score

Lotus Pharmaceutical Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Lotus Pharmaceutical Co Ltd

Wall Street analysts forecast Lotus Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Lotus Pharmaceutical Co Ltd is 473.28 TWD with a low forecast of 395.92 TWD and a high forecast of 630 TWD.

Lowest
Price Target
395.92 TWD
40% Upside
Average
Price Target
473.28 TWD
67% Upside
Highest
Price Target
630 TWD
123% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Lotus Pharmaceutical Co Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Lotus Pharmaceutical Co Ltd stock?

The intrinsic value of one Lotus Pharmaceutical Co Ltd stock under the Base Case scenario is hidden TWD.

Is Lotus Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 283 TWD, Lotus Pharmaceutical Co Ltd is hidden .

Back to Top